Brief: Matinas Biopharma Reports Q3 2022 Financial Results

Matinas BioPharma Holdings

02/11/2022 20:21

Nov 2 (Reuters) - Matinas Biopharma Holdings Inc
 MTNB.A :
    * MATINAS BIOPHARMA REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
AND HIGHLIGHTS RECENT PROGRESS
    * MATINAS BIOPHARMA HOLDINGS- $33.1 MILLION IN CASH, CASH
EQUIVALENTS, AND MARKETABLE SECURITIES AT SEP 30, 2022,
SUFFICIENT TO FUND PLANNED OPERATIONS THROUGH 2023
    * QTRLY NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS WAS
$5.5
MILLION, OR A NET LOSS OF $0.03 PER SHARE
    * Q3 EARNINGS PER SHARE VIEW $-0.03 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNXbc0rSw 
Further company coverage:  MTNB.A 
 ((Reuters.Briefs@thomsonreuters.com;))